Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China's SFDA Sets New GMP Standards

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI -- China's State Food and Drug Administration issued revised good manufacturing practice regulations Oct. 24 in an effort to increase quality systems standards for pharmaceutical manufacturers. The new standards are scheduled to go into effect Jan. 1, replacing the current GMP standards, which were implemented in 1998

You may also be interested in...



China Eager To Establish Pharmacovigilance System – SFDA Officials

SHANGHAI - In an effort to ensure drug safety, China will establish a pharmacovigilance system and will continue to improve its adverse drug reaction reports system, said Yan Ming, director of the drug re-evaluation division under China's State FDA drug safety and inspection department, during an international conference on post-market drug safety Oct. 29 in Shanghai

China Eager To Establish Pharmacovigilance System – SFDA Officials

SHANGHAI - In an effort to ensure drug safety, China will establish a pharmacovigilance system and will continue to improve its adverse drug reaction reports system, said Yan Ming, director of the drug re-evaluation division under China's State FDA drug safety and inspection department, during an international conference on post-market drug safety Oct. 29 in Shanghai

China Biologic Renews GMP Certification Under Stiffer SFDA GMP Rules

SHANGHAI- China Biologic Products has renewed its GMP certification for its production facility in Taian City in compliance with China State FDA's new, strict GMP standards, which took effect in January

UsernamePublicRestriction

Register

OM006550

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel